Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emilia Montagna
Observed names:
E Montagna,
E. Montagna,
E.S. Montagna,
Montagna, E.
Observed institutions:
University of Milan,
Federico II University Hospital,
Istituto Tumori Bari,
Ospedale Versilia,
Azienda USL Toscana Nord Ovest,
European Institute of Oncology,
University of Naples Federico II
show all 7
ORCID:
0000-0002-0384-0852
Observed ORCID:
0000-0002-0384-0852
OpenAlex ID:
A5065889459
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes
2023
·
Oreste Davide Gentilini
, Edoardo Botteri
, et al.
·
JAMA Oncology
·
593
PDF
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
2018
·
Viviana Galimberti
, Bernard F Cole
, et al.
·
The Lancet Oncology
·
574
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
2007
·
Michele De Laurentiis
, Giuseppe Cancello
, et al.
·
Journal of Clinical Oncology
·
412
PDF
A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer
2005
·
Michele De Laurentiis
, Grazia Arpino
, et al.
·
Clinical Cancer Research
·
338
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
2010
·
G. Cancello
, P. Maisonneuve
, et al.
·
Annals of Oncology
·
240
PDF
Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
2008
·
Giuseppe Viale
, Nicole Rotmensz
, et al.
·
Breast Cancer Research and Treatment
·
190
PDF
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up
2020
·
Sabrina Kahler-Ribeiro-Fontana
, Eleonora Pagan
, et al.
·
European Journal of Surgical Oncology
·
186
Invasive lobular breast cancer: subtypes and outcome
2012
·
Monica Iorfida
, Eugenio Maiorano
, et al.
·
Breast Cancer Research and Treatment
·
168
Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome
2012
·
Emilia Montagna
, Patrick Maisonneuve
, et al.
·
Clinical Breast Cancer
·
147
PDF
Outcome of special types of luminal breast cancer
2011
·
M. Colleoni
, N. Rotmensz
, et al.
·
Annals of Oncology
·
124
PDF
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse
2012
·
G. Cancello
, P. Maisonneuve
, et al.
·
Annals of Oncology
·
123
A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation
2021
·
Antonio Toesca
, Claudia Sangalli
, et al.
·
Annals of Surgery
·
118
PDF
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
2011
·
G. Cancello
, P. Maisonneuve
, et al.
·
Breast Cancer Research and Treatment
·
102
PDF
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer
2023
·
Aeson Chang
, Edoardo Botteri
, et al.
·
Science Translational Medicine
·
101
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
2008
·
Marco Colleoni
, Vincenzo Bagnardi
, et al.
·
Breast Cancer Research and Treatment
·
93
Breast cancer subtypes and outcome after local and regional relapse
2011
·
E. Montagna
, V. Bagnardi
, et al.
·
Annals of Oncology
·
76
PDF
Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression
2013
·
Alessandra Balduzzi
, Vincenzo Bagnardi
, et al.
·
Clinical Breast Cancer
·
71
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
2010
·
Emilia Montagna
, Vincenzo Bagnardi
, et al.
·
Breast Cancer Research and Treatment
·
71
Metaplastic breast cancer: Prognostic and therapeutic considerations
2020
·
Giovanni Corso
, Samuele Frassoni
, et al.
·
Journal of Surgical Oncology
·
69
Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
2012
·
Emilia Montagna
, Giuseppe Cancello
, et al.
·
Clinical Breast Cancer
·
67
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation
2011
·
Emilia Montagna
, Vincenzo Bagnardi
, et al.
·
Breast Cancer Research and Treatment
·
66
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines
2019
·
Elisabetta Munzone
, Vincenzo Bagnardi
, et al.
·
British Journal of Cancer
·
59
PDF
Neoadjuvant therapy for ER-positive breast cancers
2012
·
M. Colleoni
, E. Montagna
·
Annals of Oncology
·
59
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
2008
·
Giuseppe Cancello
, Emilia Montagna
, et al.
·
Breast Cancer Research
·
57
PDF
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019
·
M.E. Cazzaniga
, G. Pinotti
, et al.
·
The Breast
·
56
Show more works
View as search
Works count:
104
Citation count:
5,302
H-index:
37
I10-index:
63
Year
Topic
Type
